Accelerating global chemical product innovation and development

Scientific and regulatory support to market and sustain your products in any jurisdiction.

Competitive Advantage

Acta is a global scientific and regulatory consulting firm that assists companies that make and use chemicals with strategic commercialization planning and complex product registration and compliance matters.

We partner with our clients to help them get products quickly and efficiently to market — in any country or locale — and keep them there when challenged by a new regulatory regime, issue, or set of rules.

More About Us

Knowledge & Insights

  July 22, 2024
Memoranda
PFAS – What to Know Now, and What to Expect

Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are attracting global legal, regulatory, commercial, and litigation attention as no other...

  December 11, 2024
Memoranda
Senate Subcommittee Holds Hearing on Public Health Impacts of PFAS Exposures

On December 5, 2024, the Senate Environment and Public Works (EPW) Subcommittee on Chemical Safety, Waste Management, Environmental Justice, and...

  December 10, 2024
Memoranda
EPA Releases Final Supplement to the Risk Evaluation and Revised Unreasonable Risk Determination for 1,4-Dioxane

On November 13, 2024, the U.S. Environmental Protection Agency (EPA) announced the release of its final supplement to the risk evaluation and revised...

  November 22, 2024
Memoranda
EPA Releases National Strategy to Prevent Plastic Pollution

On November 21, 2024, the U.S. Environmental Protection Agency (EPA) announced the release of the National Strategy to Prevent Plastic Pollution: Part...

  November 20, 2024
Memoranda
MPCA Requests Comments on Planned PFAS in Products Reporting and Fee Rule

On November 18, 2024, the Minnesota Pollution Control Agency (MPCA) requested comments on planned rules governing reporting and fees paid by...

  November 19, 2024
Memoranda
EPA Issues ANPRM under TSCA Section 6 on 6PPD and 6PPD-Quinone

On August 1, 2023, Earthjustice filed a petition under Section 21 of the Toxic Substances Control Act (TSCA) asking the U.S. Environmental Protection...

  November 13, 2024
Memoranda
EPA Administrator Signs Final Rule Revising PBT Rules for decaBDE and PIP (3:1)

On October 31, 2024, U.S. Environmental Protection Agency (EPA) Administrator Michael S. Regan signed a final rule revising the regulations for...

Seminars & Webinars

  November 19, 2024
Seminars & Webinars
What to Expect When You Don’t Know What to Expect in Chemicals Policy and Regulation and on Capitol Hill in 2025, January 14, 2025, 11:00 a.m. – 12:00 p.m. (EST), via webinar

Registration is now open for Acta and B&C’s “What to Expect When You Don’t Know What to Expect in Chemicals Policy and Regulation and on...

  December 18, 2023
Seminars & Webinars
Consumer Labeling and the Status of GHS, April 1, 2025, 11:00 a.m. – 12:00 p.m. (EST), via webinar

B&C and Acta are pleased to present “Consumer Labeling and the Status of GHS.” More details will be posted closer to the webinar....

With offices in the U.S., UK, and Europe, and partners and agents in China, South Korea, Turkey, Mexico, and more, Acta offers expertise with regulatory programs and chemical product approvals in North America, Europe, South and Central America, and Asia.

Our Firms

our people

Experienced industry and agency scientists, including organic chemists, toxicologists, exposure experts, seven Ph.D.’s. Government affairs and regulatory specialists including nine high-level EPA alumni. Business strategists with decades of experience directing worldwide regulatory compliance.

Acta consultants manage products from concept to approval, delivering skills and experience with specific product areas in government and industry.

Our three affiliated firms -- B&C, Acta, and BCCM -- provide a full range of global support for the commercialization of chemicals, biocides, and products of industrial biotechnology, nanotechnology, and synthetic biology.